It is a pharma private limited company based in Kanpur, Uttar Pradesh, India, established in 1986.
1986 | Kanpur, Uttar Pradesh, India | ActiveAnkur Pharmaceuticals Private Limited, a active private limited company, was established on 22 October 1986 in Kanpur, Uttar Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24231UP1986PTC008301. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.13 M.
It upholds a compliant status. Its leadership includes Shivani Bvhargava (Director), Sandeep Bhargava (Additional Director), Nupur Bhargava (Additional Director). Past directors included Madhu Bhargava, Shanti Devi Bhargava, Pratibha Bhargava. It holds no open charges and ₹1.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 15/295-C Civil Lines, Kanpur, Uttar Pradesh, 208001.
U24231UP1986PTC008301
008301
22 October 1986
₹0.50 M
₹0.13 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Ankur Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shivani Bvhargava | Director | 31 Oct 1998 | Current |
| Sandeep Bhargava | Additional Director | 10 May 2021 | Current |
| Nupur Bhargava | Additional Director | 14 Jul 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Jul 2025 | Past |
| Pramod Abcsdd | Director | 07 Jun 2012 | Past |
| Pramod Abcsdd | Director | 30 Jul 2018 | Past |
| Pramod Abcsdd | Managing Director | 10 May 2021 | Past |
| Pramod Abcsdd | Director | 10 Apr 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ankur Pharmaceuticals Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 15.17% decrease. The company also saw a substantial improvement in profitability, with a 60.64% increase in profit. The company's net worth Soared by an impressive increase of 45.65%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Ankur Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹1,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2004 | Icici Hfc Ltd. | ₹1.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Ankur Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ankur Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ankur Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Nupur Bhargava was appointed as a Additional Director was appointed as a Additional Director on 14 Jul 2025 & has been associated with this company since 5 months 7 days . was documented.
Ankur Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Ankur Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.
Sandeep Bhargava was appointed as a Additional Director was appointed as a Additional Director on 10 May 2021 & has been associated with this company since 4 years 7 months . was recorded as a recent event.
The activity A charge registered on 31 Mar 2004 via Charge ID 90270772 with Icici Hfc Ltd. was fully satisfied on 06 Apr 2011. was completed.
A charge with Icici Hfc Ltd. amounted to Rs. 1.50 M with Charge ID 90270772 was registered on 31 Mar 2004. was recorded as a recent event.
The CIN of Ankur Pharmaceuticals Private Limited is U24231UP1986PTC008301.
Ankur Pharmaceuticals Private Limited is headquartered at 15/295-C Civil Lines, Kanpur, Uttar Pradesh, 208001.
Ankur Pharmaceuticals Private Limited was incorporated on 22 October 1986.
The current directors of Ankur Pharmaceuticals Private Limited are
The primary industry of Ankur Pharmaceuticals Private Limited is Pharma.
Ankur Pharmaceuticals Private Limited is unlisted.
The authorized capital of Ankur Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.13 M.
The compliance status of Ankur Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX